Argenx to pick up autoimmune biotech Forte Biosciences for $2.2B

July 27, 2026 06:46 AM EDT Deals Ar­genx to pick up au­toim­mune biotech Forte Bio­sciences for $2.2B Reynald Castaneda Deputy Editor Ar­genx will spend $2.2 bil­lion to buy Forte Bio­sciences and its an­ti-CD122 mon­o­clon­al an­ti­body that’s un­der in­ves­ti­ga­tion for au­toim­mune dis­eases. The Bel­gian-Dutch phar­ma said Mon­day … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER